Key result
Pitavastatin increases endothelial thrombomodulin expression via Rac/Cdc42 inhibition without inducing tissue factor.
Answers are grounded in this paper and cite their sources.
Demonstrates that pitavastatin upregulates thrombomodulin expression in endothelial cells by inhibiting Rac and Cdc42, suggesting an antithrombotic mechanism independent of lipid lowering.
OBJECTIVE: 3-hydroxyl-3-methyl coenzyme A reductase inhibitors (statins) can function to protect the vasculature in a manner that is independent of their lipid-lowering activity. The main feature of the antithrombotic properties of endothelial cells is an increase in the expression of thrombomodulin (TM) without induction of tissue factor (TF) expression. We investigated the effect of statins on the expression of TM and TF by endothelial cells. METHODS AND RESULTS: The incubation of endothelial cells with pitavastatin led to a concentration- and time-dependent increase in cellular TM antigen and mRNA levels. In contrast, the expression of TF mRNA was not induced under the same conditions. A nuclear run-on study revealed that pitavastatin accelerates TM transcription rate. The stimulation of TM expression by pitavastatin was prevented by either mevalonate or geranylgeranylpyrophosphate. Specific inhibition of geranylgeranyltransferase-I and Rac/Cdc42 by GGTI-286 and Clostridium sordellii lethal toxin, respectively, enhanced TM expression, whereas inactivation of Rho by Clostridium botulinum C3 exoenzyme was ineffective. CONCLUSIONS: Statins regulate TM expression via inhibition of small G proteins of the Rho family; Rac/Cdc42. A statin-mediated increase in TM expression by endothelial cells may contribute to the beneficial effects of statins on endothelial function.
No takes yet. Share an insight, caveat, or question.
Masamura et al. (2003) studied Endothelial function / Vascular thrombosis. Pitavastatin was evaluated on Cellular thrombomodulin (TM) antigen and mRNA expression and tissue factor (TF) mRNA expression. Pitavastatin caused a concentration- and time-dependent increase in endothelial thrombomodulin expression via Rac/Cdc42 inhibition without inducing tissue factor.
Synapse has enriched 10 related papers. Consider them for comparative context: